Looking forward to genetically edited fruit crops

Slides:



Advertisements
Similar presentations
Genome Editing Dieter Steinmetz ZMBP Universität Tübingen Kurs SS 2015.
Advertisements

Speciation by symbiosis Robert M. Brucker, Seth R. Bordenstein Trends in Ecology & Evolution Volume 27, Issue 8, Pages (August 2012) DOI: /j.tree
The case:  2005: No production Continued sampling  2006: Detected plants expressing transgene - demonstrated pollen transfer and seed dispersal (Reichman.
Multifaceted roles for lipids in viral infection Nicholas S. Heaton, Glenn Randall Trends in Microbiology Volume 19, Issue 7, Pages (July 2011)
Advances in shaking technologies Wolf Klöckner, Jochen Büchs Trends in Biotechnology Volume 30, Issue 6, Pages (June 2012) DOI: /j.tibtech
How do emotion and motivation direct executive control? Luiz Pessoa Trends in Cognitive Sciences Volume 13, Issue 4, Pages (April 2009) DOI: /j.tics
Lecture-7 Genome editing CRISPR
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
The Fall of Oil Prices and the Effects on Biofuels Fernando H. Reboredo, Fernando Lidon, Fernanda Pessoa, José C. Ramalho Trends in Biotechnology Volume.
Healthy clocks, healthy body, healthy mind Akhilesh B. Reddy, John S. O’Neill Trends in Cell Biology Volume 20, Issue 1, Pages (January 2010) DOI:
Primary microcephaly: do all roads lead to Rome? Gemma K. Thornton, C. Geoffrey Woods Trends in Genetics Volume 25, Issue 11, Pages (November 2009)
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Genome Editing by Matthew Porteus Department of Pediatrics,
Genome editing to breed better plants
METHODS OF GENOME ENGINEERING: A NEW ERA OF MOLECULAR BIOLOGY
Ali Zarei1,2*, Seyed Mohammad BagherTabei3, Vahid Razban4,5
Plant biotechnology: research behind fences
Eduardo Anitua, Roberto Prado, Gorka Orive  Trends in Biotechnology 
Intelligent software for laboratory automation
Institute of Health and Biomedical Innovation
Pluripotent stem cell based gene therapy for hematological diseases
Rachel Wynberg, Sarah A. Laird  Trends in Biotechnology 
Pace of Biotechnology Development
Next Assignment Presentation on genome editing
CRISPR + CAS = Defensive or Immune System
Dieter Steinmetz Universität Tübingen – ZMBP Kurs WS 15/16
Biobased plastics in a bioeconomy
Are GM Crops for Yield and Resilience Possible?
Aaron Tan, Mohammad S. Alavijeh, Alexander M. Seifalian 
Identifying and validating biomarkers for Alzheimer's disease
ZNF217/ZFP217 Meets Chromatin and RNA
Can We Get Rid of Palm Oil?
Adding Specificity to Artificial Transcription Activators
Identifying and validating biomarkers for Alzheimer's disease
Volume 21, Issue 20, Pages R837-R838 (October 2011)
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Gene therapy—where are we?
Astrid Breitbart, Charles E. Murry  Cell Stem Cell 
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Feasibility of new breeding techniques for organic farming
Astrid Breitbart, Charles E. Murry  Cell Stem Cell 
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
CRISPR genome-editing: A medical revolution
Osteoarthritis year 2013 in review: genetics and genomics
Volume 175, Issue 1, Pages 6-9 (September 2018)
Zinc Fingers, TAL Effectors, or Cas9-Based DNA Binding Proteins: What’s Best for Targeting Desired Genome Loci?  Annett Strauβ, Thomas Lahaye  Molecular.
Plant Pathogen Effectors: Getting Mixed Messages
Nicholas D Weber, Daniel Stone, Keith R Jerome  Molecular Therapy 
The Evolution of Antiviral Defense Systems
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
Gene transfer © 2016 Paul Billiet ODWS.
Genome Editing Technologies: Defining a Path to Clinic
Unjustified regulation prevents use of GMO technology for public good
A CRISPR Approach to Gene Targeting
Moonjung Jung, Cynthia E Dunbar, Thomas Winkler  Molecular Therapy 
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
FOXO transcription factors
A Welcome Proposal to Amend the GMO Legislation of the EU
Volume 21, Issue 9, Pages (September 2014)
A-Andrew D. Jones, Gujie Mi, Thomas J. Webster  Trends in Biotechnology 
CRISPR/Cas Systems towards Next-Generation Biosensing
Drug target miRNAs: chances and challenges
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Microbials for the production of monoclonal antibodies and antibody fragments  Oliver Spadiut, Simona Capone, Florian Krainer, Anton Glieder, Christoph.
Volume 21, Issue 9, Pages (September 2014)
Presentation transcript:

Looking forward to genetically edited fruit crops Chidananda Nagamangala Kanchiswamy, Daniel James Sargent, Riccardo Velasco, Massimo E. Maffei, Mickael Malnoy  Trends in Biotechnology  Volume 33, Issue 2, Pages 62-64 (February 2015) DOI: 10.1016/j.tibtech.2014.07.003 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Comparison between genetic modification technologies. Top left, introduction of foreign DNA. Bottom left, emerging technologies such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regulatory interspaced short palindromic repeat (CRISPR)/Cas-based RNA-guided DNA endonucleases. Right, fruits for which genes have already been modified to fight biotic and abiotic stress [16]. Red background: not generally acceptable to the public. Green: background: more acceptable to the public. Trends in Biotechnology 2015 33, 62-64DOI: (10.1016/j.tibtech.2014.07.003) Copyright © 2014 Elsevier Ltd Terms and Conditions